Increased serum autotaxin levels in hepatocellular carcinoma patients were caused by background liver fibrosis but not by carcinoma-Reference-Cited by-同舟云学术

Increased serum autotaxin levels in hepatocellular carcinoma patients were caused by background liver fibrosis but not by carcinoma

Published:2014-06 Issue: Volume:433 Page:128-134
ISSN:0009-8981
Container-title:Clinica Chimica Acta
language:en
Short-container-title:Clinica Chimica Acta

Author:

Kondo Mayuko,Ishizawa Takeaki,Enooku Kenichiro,Tokuhara Yasunori,Ohkawa Ryunosuke,Uranbileg Baasanjav,Nakagawa Hayato,Tateishi Ryosuke,Yoshida Haruhiko,Kokudo Norihiro,Koike Kazuhiko,Yatomi Yutaka,Ikeda Hitoshi

Publisher

Elsevier BV

Subject

Biochemistry, medical,Clinical Biochemistry,Biochemistry,General Medicine

Reference36 articles.

1. Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein;Stracke;J Biol Chem,1992

2. Autotaxin, tumor motility-stimulating exophosphodiesterase;Stracke;Adv Enzym Regul,1997

3. Induction of autotaxin by the Epstein–Barr virus promotes the growth and survival of Hodgkin lymphoma cells;Baumforth;Blood,2005

4. Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid;Kishi;J Biol Chem,2006

5. Autotaxin expression in non-small-cell lung cancer;Yang;Am J Respir Cell Mol Biol,1999

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Value of autotaxin for hepatocellular carcinoma risk assessment in chronic hepatitis B patients treated with nucleos(t)ide analogs;Hepatology Research;2024-03-27

2. Utility of serum autotaxin levels for predicting post hepatectomy liver failure in hepatocellular carcinoma;Journal of Hepato-Biliary-Pancreatic Sciences;2022-12-05

3. A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis;EMBO Molecular Medicine;2022-07-14

4. Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer;Frontiers in Oncology;2022-06-13

5. A type IV Autotaxin inhibitor ameliorates acute liver injury and non-alcoholic steatohepatitis in mice;2022-05-19